SynthesisClinical drug investigation2022

Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.

Feiyu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.